AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2019
Feb 11, 2019
35066_dirs_2019-02-11_bfef326f-7817-48e7-9988-5f9ce8446a11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2019-02-01
Reporting Person: Brady Todd R. (Director)
More from Cocrystal Pharma, Inc.
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19